z-logo
open-access-imgOpen Access
A novel mutation in VCP causes Charcot–Marie–Tooth Type 2 disease
Author(s) -
Michael Gonzalez,
Shawna Feely,
Fiorella Speziani,
Alleene V. Strickland,
Matt C. Danzi,
Chelsea Bacon,
Youjin Lee,
TsuiFen Chou,
Susan H. Blanton,
Conrad C. Weihl,
Stephan Züchner,
Michael E. Shy
Publication year - 2014
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awu224
Subject(s) - tooth disease , mutation , disease , genetics , medicine , biology , pathology , gene
Mutations in VCP have been reported to account for a spectrum of phenotypes that include inclusion body myopathy with Paget's disease of the bone and frontotemporal dementia, hereditary spastic paraplegia, and 1-2% of familial amyotrophic lateral sclerosis. We identified a novel VCP mutation (p.Glu185Lys) segregating in an autosomal dominant Charcot-Marie-Tooth disease type 2 family. Functional studies showed that the Glu185Lys variant impaired autophagic function leading to the accumulation of immature autophagosomes. VCP mutations should thus be considered for genetically undefined Charcot-Marie-Tooth disease type 2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom